Molecular Modeling Unveils the Effective Interaction of B-RAF Inhibitors with Rare B-RAF Insertion Variants
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241512285 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Maria Chiara Scaini und 13 weiteren Autor:innen. Beteiligte Einrichtung: Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Istituto Oncologico Veneto, Italian Ministry of Health.
Abstract (Originalsprache)
The Food and Drug Administration (FDA) has approved MAPK inhibitors as a treatment for melanoma patients carrying a mutation in codon V600 of the BRAF gene exclusively. However, BRAF mutations outside the V600 codon may occur in a small percentage of melanomas. Although these rare variants may cause B-RAF activation, their predictive response to B-RAF inhibitor treatments is still poorly understood. We exploited an integrated approach for mutation detection, tumor evolution tracking, and assessment of response to treatment in a metastatic melanoma patient carrying the rare p.T599dup B-RAF mutation. He was addressed to Dabrafenib/Trametinib targeted therapy, showing an initial dramatic response. In parallel, in-silico ligand-based homology modeling was set up and performed on this and an additional B-RAF rare variant (p.A598_T599insV) to unveil and justify the success of the B-RAF inhibitory activity of Dabrafenib, showing that it could adeptly bind both these variants in a similar manner to how it binds and inhibits the V600E mutant. These findings open up the possibility of broadening the spectrum of BRAF inhibitor-sensitive mutations beyond mutations at codon V600, suggesting that B-RAF V600 WT melanomas should undergo more specific investigations before ruling out the possibility of targeted therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy.
- Melanoma Unit, Oncology 2 Unit, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy.
- Molecular Modeling Section (MMS), Department of Pharmaceutical and Pharmacological Sciences, University of Padova, 35131 Padua, Italy.
- Anatomy and Pathological Histology Unit, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy.
- Soft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy.
- Department of Surgery, Oncology and Gastroenterology (DISCOG), University of Padua, 35128 Padua, Italy.
ORCID-Profile: Maria Chiara Scaini, Davide Bassani, Stefania Pellegrini, Cristina Poggiana, Cristina Catoni, Jacopo Pigozzo, Luigi Dall'Olmo, Antonio Rosato, Stefano Moro, Vanna Chiarion-Sileni, Chiara Menin
Förderung
- Ministero della Salute
- Istituto Oncologico Veneto
- Italian Ministry of Health
Zitieren
APA
Scaini, M. C., Piccin, L., Bassani, D., Scapinello, A., Pellegrini, S., Poggiana, C., Catoni, C., Tonello, D., Pigozzo, J., Dall'Olmo, L., Rosato, A., Moro, S., Chiarion-Sileni, V., & Menin, C. (2023). Molecular Modeling Unveils the Effective Interaction of B-RAF Inhibitors with Rare B-RAF Insertion Variants. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241512285
Vancouver
Scaini MC, Piccin L, Bassani D, Scapinello A, Pellegrini S, Poggiana C, et al. Molecular Modeling Unveils the Effective Interaction of B-RAF Inhibitors with Rare B-RAF Insertion Variants. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241512285
BibTeX
@article{Scaini2023,
author = {Scaini, Maria Chiara and Piccin, Luisa and Bassani, Davide and Scapinello, Antonio and Pellegrini, Stefania and Poggiana, Cristina and Catoni, Cristina and Tonello, Debora and Pigozzo, Jacopo and Dall'Olmo, Luigi and Rosato, Antonio and Moro, Stefano and Chiarion-Sileni, Vanna and Menin, Chiara},
title = {Molecular Modeling Unveils the Effective Interaction of B-RAF Inhibitors with Rare B-RAF Insertion Variants},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241512285}
}
EUVIMED